Unveiling the Hepatic Harbinger: Assessing the Fatty Liver Index As a Predictor of Metabolic Syndrome in Female Healthcare Workers

Overview

Journal Indian J Occup Environ Med

Date 2025 Jan 29

PMID 39877281

Authors

M Yogesh

Roshni Vamja

Vijay Vala

Arya Ramachandran

Bhumika Surati

Jay Nagda

Affiliations

Soon will be listed here.

Abstract

Background: Female healthcare workers have unique occupational stressors and lifestyle factors that may increase their risk of metabolic disorders. This study aimed to investigate the utility of the fatty liver index (FLI) as a predictor of metabolic syndrome among female employees in the healthcare sector.

Methods: This cross-sectional study included 450 female healthcare workers aged ≥18 years, employed in various roles at a tertiary healthcare facility in Gujarat. Clinical examination, anthropometric measurements, and biochemical tests were conducted. FLI was calculated, and metabolic syndrome was diagnosed using harmonized criteria. Logistic regression analysis evaluated predictors.

Results: The mean age was 44.2 ± 7.8 years, and the prevalence of metabolic syndrome was 61%. Increasing the FLI category was significantly associated with a worsening metabolic profile. The odds of hypertension, diabetes, metabolic syndrome, and cardiovascular disease progressively increased with higher FLI levels ( < 0.001), denoting a dose-response relationship. FLI demonstrated good diagnostic accuracy for metabolic syndrome with an area under the curve (AUC) of 0.86 (95% CI: 0.81 - 0.89). An FLI cutoff ≥30 provided an optimal balance of sensitivity (71%) and specificity (41%) for predicting metabolic syndrome.

Conclusion: FLI demonstrates a strong association with metabolic syndrome and related comorbidities in a dose-dependent manner. FLI can be a simple, low-cost screening tool to identify high metabolic risk individuals in resource-limited settings.

References

Zhang T, Zhang Y, Zhang C, Tang F, Li H, Zhang Q . Prediction of metabolic syndrome by non-alcoholic fatty liver disease in northern urban Han Chinese population: a prospective cohort study. PLoS One. 2014; 9(5):e96651. PMC: 4011868. DOI: 10.1371/journal.pone.0096651. View

Cornier M, Despres J, Davis N, Grossniklaus D, Klein S, Lamarche B . Assessing adiposity: a scientific statement from the American Heart Association. Circulation. 2011; 124(18):1996-2019. DOI: 10.1161/CIR.0b013e318233bc6a. View

Kwon Y, Oh S, Hwang S, Lee C, Kwon H, Chung G . Association of nonalcoholic fatty liver disease with components of metabolic syndrome according to body mass index in Korean adults. Am J Gastroenterol. 2012; 107(12):1852-8. DOI: 10.1038/ajg.2012.314. View

Xu C, Yu C, Ma H, Xu L, Miao M, Li Y . Prevalence and risk factors for the development of nonalcoholic fatty liver disease in a nonobese Chinese population: the Zhejiang Zhenhai Study. Am J Gastroenterol. 2013; 108(8):1299-304. DOI: 10.1038/ajg.2013.104. View

Bugianesi E, McCullough A, Marchesini G . Insulin resistance: a metabolic pathway to chronic liver disease. Hepatology. 2005; 42(5):987-1000. DOI: 10.1002/hep.20920. View

Petta S, Amato M, Di Marco V, Camma C, Pizzolanti G, Barcellona M . Visceral adiposity index is associated with significant fibrosis in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2011; 35(2):238-47. DOI: 10.1111/j.1365-2036.2011.04929.x. View

Genuth S, Alberti K, Bennett P, Buse J, DeFronzo R, Kahn R . Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. 2003; 26(11):3160-7. DOI: 10.2337/diacare.26.11.3160. View

Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A . The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006; 6:33. PMC: 1636651. DOI: 10.1186/1471-230X-6-33. View

Paredes A, Torres D, Harrison S . Nonalcoholic fatty liver disease. Clin Liver Dis. 2012; 16(2):397-419. DOI: 10.1016/j.cld.2012.03.005. View

10.

Han A . Validation of fatty liver index as a marker for metabolic dysfunction-associated fatty liver disease. Diabetol Metab Syndr. 2022; 14(1):44. PMC: 8939216. DOI: 10.1186/s13098-022-00811-2. View

11.

Bhatt H, Smith R . Fatty liver disease in diabetes mellitus. Hepatobiliary Surg Nutr. 2015; 4(2):101-8. PMC: 4405411. DOI: 10.3978/j.issn.2304-3881.2015.01.03. View

12.

Garofolo M, Lucchesi D, Giambalvo M, Aragona M, Bertolotto A, Campi F . Fatty liver index is an independent risk factor for all-cause mortality and major cardiovascular events in type 1 diabetes: an 11-year observational study. Cardiovasc Diabetol. 2024; 23(1):85. PMC: 10902974. DOI: 10.1186/s12933-024-02171-9. View

13.

Khang A, Lee H, Yi D, Kang Y, Son S . The fatty liver index, a simple and useful predictor of metabolic syndrome: analysis of the Korea National Health and Nutrition Examination Survey 2010-2011. Diabetes Metab Syndr Obes. 2019; 12:181-190. PMC: 6353218. DOI: 10.2147/DMSO.S189544. View

14.

Prati D, Taioli E, Zanella A, Della Torre E, Butelli S, Del Vecchio E . Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med. 2002; 137(1):1-10. DOI: 10.7326/0003-4819-137-1-200207020-00006. View

15.

Dasgupta A, Banerjee R, Pan T, Suman S, Basu U, Paul B . Metabolic syndrome and its correlates: A cross-sectional study among adults aged 18-49 years in an Urban Area of West Bengal. Indian J Public Health. 2020; 64(1):50-54. DOI: 10.4103/ijph.IJPH_50_19. View

16.

Cushman W, Cutler J, Bingham S, Harford T, Hanna E, Dubbert P . Prevention and Treatment of Hypertension Study (PATHS). Rationale and design. Am J Hypertens. 1994; 7(9 Pt 1):814-23. DOI: 10.1093/ajh/7.9.814. View

17.

Uchil D, Pipalia D, Chawla M, Patel R, Maniar S, Narayani . Non-alcoholic fatty liver disease (NAFLD)--the hepatic component of metabolic syndrome. J Assoc Physicians India. 2009; 57:201-4. View

18.

Alberti K, Eckel R, Grundy S, Zimmet P, Cleeman J, Donato K . Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation;.... Circulation. 2009; 120(16):1640-5. DOI: 10.1161/CIRCULATIONAHA.109.192644. View

19.

Prasad D, Kabir Z, Dash A, Das B . Prevalence and risk factors for metabolic syndrome in Asian Indians: A community study from urban Eastern India. J Cardiovasc Dis Res. 2012; 3(3):204-11. PMC: 3425027. DOI: 10.4103/0975-3583.98895. View

20.

Olubamwo O, Virtanen J, Pihlajamaki J, Tuomainen T . Association of fatty liver index with risk of incident type 2 diabetes by metabolic syndrome status in an Eastern Finland male cohort: a prospective study. BMJ Open. 2019; 9(7):e026949. PMC: 6615775. DOI: 10.1136/bmjopen-2018-026949. View